In the Phase 3 TEMPO program, AbbVie’s Juvmo elicited significant improvements in motor symptoms and prolonged periods with ...
Juvmo was designed to offer a reduction in motor symptoms, while reducing non-motor side effects, through its more selective ...
Parkinson’s disease is a neurodegenerative disorder characterized by the progressive loss of dopamine-producing nerve cells in the brain, leading to motor slowing, gait and balance problems and ...
A new study by investigators from the Mass General Brigham Neuroscience Institute has identified common genetic variants in the MC1R gene as markers of faster motor decline in people with Parkinson's ...
Digestive symptoms often appear years before tremor in Parkinson’s disease, and growing evidence suggests the gut-brain axis may play a critical role in early disease processes and symptom management.
AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved JUVMO™ (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for the treatment of ...
Mr. Xu recently experienced unsteadiness while walking and some “clunking” sound in his movements. He was subsequently diagnosed with Parkinson’s disease. After his doctor prescribed a low-dose ...
Since its inception in 2000, The Michael J. Fox Foundation has become the world’s largest nonprofit funder of Parkinson’s research, recently marking over $3 billion in total contributions toward ...
Freezing of Gait (FOG) is a disabling feature of Parkinson’s disease (PD). However, the neural mechanisms underlying voluntary stopping impairments remain unclear. This study used a validated Virtual ...
Michael J. Fox established The Michael J. Fox Foundation for Parkinson's Research in 2000 after his diagnosis. The foundation has funded over $3 billion in research aimed at developing treatments and ...
A growing body of research suggests that what you eat can play a role in leading to Parkinson’s or even speed up the progression of the disease. The connection between your gut and Parkinson’s disease ...